The announcement by the Therapeutic Goods Administration that pharmaceutical products that contain codeine will no longer be available over the counter in 2018 has been met with resistance by the Australian Self Medication Industry and many ordinary Australians who rely on these medications for self-management of pain.
Medications containing codeine will be Schedule 4 drugs from February 2018, meaning that for people to obtain them, they will have to get a prescription from a GP.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in